In cancer, the expression pattern of Sp2 is inversely correlated with CEACAM1 expression in prostate cancer cells, likely due to its role in recruiting histone deacetylase to the CEACAM1 promoter (downregulation of a tumor suppressor gene)45. This evidence concerns the gene SP2 and prostate carcinoma.